|
1
|
Wang L, Gao P, Zhang M, Huang Z, Zhang D,
Deng Q, Li Y, Zhao Z, Qin X, Jin D, et al: Prevalence and ethnic
pattern of diabetes and prediabetes in China in 2013. JAMA.
317:2515–2523. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Haass NK, Nassif N and McGowan EM:
Switching the sphingolipid rheostat in the treatment of diabetes
and cancer comorbidity from a problem to an advantage. Biomed Res
Int. 2015:1651052015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Billings LK and Florez JC: The genetics of
type 2 diabetes: What have we learned from GWAS? Ann N Y Acad Sci.
1212:59–77. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fayyaz S, Japtok L and Kleuser B:
Divergent role of sphingosine 1-phosphate on insulin resistance.
Cell Physiol Biochem. 34:134–147. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Silva VR, Micheletti TO, Pimentel GD,
Katashima CK, Lenhare L, Morari J, Mendes MC, Razolli DS, Rocha GZ,
de Souza CT, et al: Hypothalamic S1P/S1PR1 axis controls energy
homeostasis. Nat Commun. 5:48592014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Spiegel S and Milstien S: Functions of a
new family of sphingosine-1-phosphate receptors. Biochim Biophys
Acta. 1484:107–116. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pulkoski-Gross MJ, Donaldson JC and Obeid
LM: Sphingosine-1-phosphate metabolism: A structural perspective.
Crit Rev Biochem Mol Biol. 50:298–313. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Maceyka M, Harikumar KB, Milstien S and
Spiegel S: Sphingosine-1-phosphate signaling and its role in
disease. Trends Cell Biol. 22:50–60. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pyne S and Pyne NJ: New perspectives on
the role of sphingosine 1-phosphate in cancer. Handb Exp Pharmacol.
55–71. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cuvillier O, Pirianov G, Kleuser B, Vanek
PG, Coso OA, Gutkind S and Spiegel S: Suppression of
ceramide-mediated programmed cell death by sphingosine-1-phosphate.
Nature. 381:800–803. 1996. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gómez-Muñoz A, Waggoner DW, O'Brien L and
Brindley DN: Interaction of ceramides, sphingosine, and sphingosine
1-phosphate in regulating DNA synthesis and phospholipase D
activity. J Biol Chem. 270:26318–26325. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pyne S and Pyne NJ: The differential
regulation of cyclic AMP by sphingomyelin-derived lipids and the
modulation of sphingolipid-stimulated extracellular signal
regulated kinase-2 in airway smooth muscle. Biochem J. 315:917–923.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hatoum D, Haddadi N, Lin Y, Nassif NT and
McGowan EM: Mammalian sphingosine kinase (SphK) isoenzymes and
isoform expression: Challenges for SphK as an oncotarget.
Oncotarget. 8:36898–36929. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Spiegel S and Milstien S:
Sphingosine-1-phosphate: Signaling inside and out. FEBS Lett.
476:55–57. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Strub GM, Maceyka M, Hait NC, Milstien S
and Spiegel S: Extracellular and intracellular actions of
sphingosine-1-phosphate. Adv Exp Med Biol. 688:141–155. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Obinata H and Hla T: Sphingosine
1-phosphate in coagulation and inflammation. Semin Immunopathol.
34:73–91. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Blaho VA and Hla T: An update on the
biology of sphingosine 1-phosphate receptors. J Lipid Res.
55:1596–1608. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kihara Y, Maceyka M, Spiegel S and Chun J:
Lysophospholipid receptor nomenclature review: IUPHAR Review 8. Br
J Pharmacol. 171:3575–3594. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang F, Van Brocklyn JR, Hobson JP,
Movafagh S, Zukowska-Grojec Z, Milstien S and Spiegel S:
Sphingosine 1-phosphate stimulates cell migration through a
G(i)-coupled cell surface receptor. Potential involvement in
angiogenesis. J Biol Chem. 274:35343–35350. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ishii I, Fukushima N, Ye X and Chun J:
Lysophospholipid receptors: Signaling and biology. Annu Rev
Biochem. 73:321–354. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Takuwa Y, Okamoto Y, Yoshioka K and Takuwa
N: Sphingosine- 1-phosphate signaling in physiology and diseases.
Biofactors. 38:329–337. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Völzke A, Koch A, Meyer ZHD, Huwiler A and
Pfeilschifter J: Sphingosine 1-phosphate (S1P) induces COX-2
expression and PGE2 formation via S1P receptor 2 in renal mesangial
cells. Biochim Biophys Acta. 1841:11–21. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Takuwa Y, Takuwa N and Sugimoto N: The Edg
family G protein-coupled receptors for lysophospholipids: Their
signaling properties and biological activities. J Biochem.
131:767–771. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Brinkmann V: Sphingosine 1-phosphate
receptors in health and disease: Mechanistic insights from gene
deletion studies and reverse pharmacology. Pharmacol Ther.
115:84–105. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mandala S, Hajdu R, Bergstrom J,
Quackenbush E, Xie J, Milligan J, Thornton R, Shei GJ, Card D,
Keohane C, et al: Alteration of lymphocyte trafficking by
sphingosine-1-phosphate receptor agonists. Science. 296:346–349.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Taha TA, Argraves KM and Obeid LM:
Sphingosine-1-phosphate receptors: Receptor specificity versus
functional redundancy. Biochim Biophys Acta. 1682:48–55. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Laychock SG, Tian Y and Sessanna SM:
Endothelial differentiation gene receptors in pancreatic islets and
INS-1 cells. Diabetes. 52:1986–1993. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Serafimidis I, Rodriguez-Aznar E, Lesche
M, Yoshioka K, Takuwa Y, Dahl A, Pan D and Gavalas A: Pancreas
lineage allocation and specification are regulated by
sphingosine-1-phosphate signalling. PLoS Biol. 15:e20009492017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Matthews DR, Hosker JP, Rudenski AS,
Naylor BA, Treacher DF and Turner RC: Homeostasis model assessment:
Insulin resistance and beta-cell function from fasting plasma
glucose and insulin concentrations in man. Diabetologia.
28:412–419. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Butler AE, Janson J, Bonner-Weir S, Ritzel
R, Rizza RA and Butler PC: Beta-cell deficit and increased
beta-cell apoptosis in humans with type 2 diabetes. Diabetes.
52:102–110. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ashcroft FM and Rorsman P: Diabetes
mellitus and the β cell: The last ten years. Cell. 148:1160–1171.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bonner-Weir S, Li WC, Ouziel-Yahalom L,
Guo L, Weir GC and Sharma A: Beta-cell growth and regeneration:
Replication is only part of the story. Diabetes. 59:2340–2348.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mandrup-Poulsen T: beta-cell apoptosis:
Stimuli and signaling. Diabetes. 50 (Suppl 1):S58–S63. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kim RH, Takabe K, Milstien S and Spiegel
S: Export and functions of sphingosine-1-phosphate. Biochim Biophys
Acta. 1791:692–696. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wei Q, Deng H, Cui H, Fang J, Zuo Z, Deng
J, Li Y, Wang X and Zhao L: A mini review of fluoride-induced
apoptotic pathways. Environ Sci Pollut Res Int. 25:33926–33935.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Guo H, Chen L, Cui H, Peng X, Fang J, Zuo
Z, Deng J, Wang X and Wu B: Research advances on pathways of
nickel-induced apoptosis. Int J Mol Sci. 17:E102015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Qi Y, Chen J, Lay A, Don A, Vadas M and
Xia P: Loss of sphingosine kinase 1 predisposes to the onset of
diabetes via promoting pancreatic beta-cell death in diet-induced
obese mice. FASEB J. 27:4294–4304. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xia P, Wang L, Gamble JR and Vadas MA:
Activation of sphingosine kinase by tumor necrosis factor-alpha
inhibits apoptosis in human endothelial cells. J Biol Chem.
274:34499–34505. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Olivera A, Kohama T, Edsall L, Nava V,
Cuvillier O, Poulton S and Spiegel S: Sphingosine kinase expression
increases intracellular sphingosine-1-phosphate and promotes cell
growth and survival. J Cell Biol. 147:545–558. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sarkar S, Maceyka M, Hait NC, Paugh SW,
Sankala H, Milstien S and Spiegel S: Sphingosine kinase 1 is
required for migration, proliferation and survival of MCF-7 human
breast cancer cells. FEBS Lett. 579:5313–5317. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sukocheva O, Wadham C, Holmes A, Albanese
N, Verrier E, Feng F, Bernal A, Derian CK, Ullrich A, Vadas MA and
Xia P: Estrogen transactivates EGFR via the sphingosine 1-phosphate
receptor Edg-3: The role of sphingosine kinase-1. J Cell Biol.
173:301–310. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Morales A, Lee H, Goñi FM, Kolesnick R and
Fernandez-Checa JC: Sphingolipids and cell death. Apoptosis.
12:923–939. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Laychock SG, Sessanna SM, Lin MH and
Mastrandrea LD: Sphingosine 1-phosphate affects cytokine-induced
apoptosis in rat pancreatic islet beta-cells. Endocrinology.
147:4705–4712. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Shimizu H, Okajima F, Kimura T, Ohtani K,
Tsuchiya T, Takahashi H, Kuwabara A, Tomura H, Sato K and Mori M:
Sphingosine 1-phosphate stimulates insulin secretion in HIT-T 15
cells and mouse islets. Endocr J. 47:261–269. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hasan NM, Longacre MJ, Stoker SW, Kendrick
MA, Druckenbrod NR, Laychock SG, Mastrandrea LD and MacDonald MJ:
Sphingosine kinase 1 knockdown reduces insulin synthesis and
secretion in a rat insulinoma cell line. Arch Biochem Biophys.
518:23–30. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ng ML, Wadham C and Sukocheva OA: The role
of sphingolipid signalling in diabetesassociated pathologies
(Review). Int J Mol Med. 39:243–252. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Lee SY, Lee HY, Song JH, Kim GT, Jeon S,
Song YJ, Lee JS, Hur JH, Oh HH, Park SY, et al: Adipocyte-specific
deficiency of de novo sphingolipid biosynthesis leads to
lipodystrophy and insulin resistance. Diabetes. 66:2596–2609. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kitada Y, Kajita K, Taguchi K, Mori I,
Yamauchi M, Ikeda T, Kawashima M, Asano M, Kajita T, Ishizuka T, et
al: Blockade of sphingosine 1-phosphate receptor 2 signaling
attenuates high-fat diet-induced adipocyte hypertrophy and systemic
glucose intolerance in mice. Endocrinology. 157:1839–1851. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Japtok L, Schmitz EI, Fayyaz S, Krämer S,
Hsu LJ and Kleuser B: Sphingosine 1-phosphate counteracts insulin
signaling in pancreatic beta-cells via the sphingosine 1-phosphate
receptor subtype 2. FASEB J. 29:3357–3369. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Imasawa T, Koike K, Ishii I, Chun J and
Yatomi Y: Blockade of sphingosine 1-phosphate receptor 2 signaling
attenuates streptozotocin-induced apoptosis of pancreatic
beta-cells. Biochem Biophys Res Commun. 392:207–211. 2010.
View Article : Google Scholar : PubMed/NCBI
|
